(3-((2-(3,5-dimorpholinophenylamino)pyrimidin-4-yl)(methyl)amino)-4-methylphenyl)methanol

ID: ALA1762530

PubChem CID: 24894017

Max Phase: Preclinical

Molecular Formula: C27H34N6O3

Molecular Weight: 490.61

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1

Standard InChI:  InChI=1S/C27H34N6O3/c1-20-3-4-21(19-34)15-25(20)31(2)26-5-6-28-27(30-26)29-22-16-23(32-7-11-35-12-8-32)18-24(17-22)33-9-13-36-14-10-33/h3-6,15-18,34H,7-14,19H2,1-2H3,(H,28,29,30)

Standard InChI Key:  BUHNODQEWUMKMH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   18.4849  -13.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4838  -14.0982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1983  -14.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9146  -14.0978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9118  -13.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1965  -12.8585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6295  -14.5090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1940  -12.0337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9091  -11.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9086  -10.7988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1948  -10.3846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4800  -10.7979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4789  -11.6253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7692  -14.5101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0527  -14.0943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3403  -14.5026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3354  -15.3277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0491  -15.7429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7678  -15.3328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3432  -14.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0546  -14.5072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7679  -14.0944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7670  -13.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0470  -12.8577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3369  -13.2729    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0428  -12.0329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7550  -11.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1798  -10.7871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7497  -10.7962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4568  -10.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1836  -11.6127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4742  -12.0244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3265  -11.6242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4786  -12.8491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4490   -9.5571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1594   -9.1379    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
  4  5  1  0
  7 20  1  0
  2  3  1  0
 20 21  2  0
  5  6  2  0
 21 22  1  0
  6  1  1  0
 22 23  2  0
  8 13  1  0
 23 24  1  0
  9 10  1  0
 24 25  2  0
 25 20  1  0
 10 11  1  0
 24 26  1  0
 11 12  1  0
 26 27  1  0
 27 32  2  0
 12 13  1  0
 31 28  2  0
 28 30  1  0
 29 27  1  0
 29 30  2  0
  1  2  2  0
  2 14  1  0
 31 32  1  0
 14 15  1  0
  4  7  1  0
  3  4  2  0
 26 33  1  0
  6  8  1  0
 32 34  1  0
  8  9  1  0
 30 35  1  0
 35 36  1  0
M  END

Associated Targets(Human)

CSK Tchem Tyrosine-protein kinase CSK (2395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 490.61Molecular Weight (Monoisotopic): 490.2692AlogP: 3.46#Rotatable Bonds: 7
Polar Surface Area: 86.22Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.66CX Basic pKa: 4.53CX LogP: 3.95CX LogD: 3.95
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.52Np Likeness Score: -1.06

References

1. Barlaam B, Ducray R, Lambert-van der Brempt C, Plé P, Bardelle C, Brooks N, Coleman T, Cross D, Kettle JG, Read J..  (2011)  Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series.,  21  (8): [PMID:21441027] [10.1016/j.bmcl.2011.03.009]
2. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]